Intermountain Healthcare, a Utah-based healthcare system, is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes and sustainable costs. Recently, Kirk U. Knowlton, MD,...
Cardiovascular Disease
Category
AHA-Backed Study Reveals Ongoing Lack of Minority & Female Participation in Cardiometabolic Clinical Trials
Unfortunately, yet another report reveals the dearth of women and minorities, especially African Americans’ representation in clinical trials in the critically important cardiovascular and metabolic therapeutic domain. The results of a recent study published in the...
Insomnia as a Risk Factor for Heart Disease
Heart disease and sleeping pills are one of those combinations that can come with a potential risk. Although insomnia is frequent among the healthy population, around 20% of medical patients are also struggling with it. Among medical patients, the group that struggles...
University of Kansas a Leading Site in Clinical Trial Assessing Drug Affecting High Cholesterol from Genes
A clinical investigator from the University of Kansas School of Medicine, Patrick M. Moriarty, co-led a clinical trial testing a drug focusing on individuals who have inherited a condition subjecting them to high cholesterol irrespective of diet or lifestyle. The...
University of Oxford to Study Rare Inherited Heart Disease in Effort to Safeguard More Children
The UK’s University of Oxford is conducting a new study that could prevent young people from suffering a fatal cardiac arrest due to a rare inherited heart disease. Financed by the British Heart Foundation, the research seeks to address CPVT, also known as...
Akcea and Ionis Report Positive Phase 2 Data for AKCEA-ANGPTL3-LRx; Asset Transferred to Pfizer
Akcea Therapeutics along with its parent company, Ionis Pharmaceuticals, announced positive topline results from the Phase 2 study of AKCEA-ANGPTL3-LRx in patients with hypertriglyceridemia, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). The study met...
Akcea and Ionis Report Positive Topline Phase 2 Results of AKCEA-APOCIII-L Rx in Patients with Hypertriglyceridemia
Akcea Therapeutics, a majority owned affiliate of Ionis Pharmaceuticals, announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of patients with hypertriglyceridemia who are at risk for or have established cardiovascular...
The Future of Cardio Care: Assessment, Genetics and AI
According to Dr. Irving Kent Loh, chief medical officer and co-founder of Infermedica, an artificial intelligence in healthcare company focused on clinical decision support, the future of healthcare is headed for vast changes in the next decade. Dr. Loh, a...
Heart Stenting vs. Surgery Triggers Controversy in Europe: Is a BBC Story Accurate?
Some European doctors recently backed away from the findings of a major study that found bypass surgery and stents are equally effective at preventing heart disease deaths when a major heart artery is clogged. There has been growing preference for stents as they allow...
Mayo Clinic-Led Study Findings Recommends Need for Screening Rheumatoid Arthritis Patients for Comorbidities
A Mayo Clinic-led research team has concluded that the presence of comorbidities, such as inflammatory bowel disease, type 1 diabetes, venous thromboembolism, cardiovascular disease and obstructive sleep apnea may either predispose patients to rheumatoid arthritis...
UT Southwestern Researchers Identify Potential Biomarker Blood Test for Future Cardiovascular Trouble
Preventive cardiology researchers at UT Southwestern Medical Center have been on a mission to look for new ways to detect early stage heart disease in people who are not currently in treatment. They now believe that a new blood test for protein biomarkers could...
VITAL Study Involving 26,000 Participants Evidences Prevention Promise for Omega-3-Fatty Acids
The North American Menopause Society (NAMS) completed the VITamin D and OmegA-3 Trial (VITAL)., the largest and most recent test to investigate Vitamin D or fish oil can effectively prevent cancer or cardiovascular disease. Results have been generally mixed however in...
Yale Selected to Participate in Stroke Preclinical Assessment Network (SPAN) to Study Ischemic Stroke Treatments
Yale Department of Neurology received a $4 million grant from the National Institutes of Health to assess acute ischemic stroke treatments in rodent models. They are participating with other institutions in the Stroke Preclinical Assessment Network or SPAN. The...
COMPASS Trial Reveals Positive Regimen for Patients with Peripheral Artery Disease
The COMPASS trial revealed that patients with stable atherosclerotic vascular disease tremendously benefit from 2.5 mg Xarelto twice daily, plus 100 mg aspirin once daily. This regimen was found to have not only reduced the risk of a second cardiovascular event (e.g.,...
Kaiser Permanente Northern California Large Observational Study Reveals Very Low Ldl Could Be Protective in Diabetic Dyslipidemia
A Kaiser Permanente Northern California-led large observational study reveals that achieving very low levels of low-density lipoprotein (LDL) cholesterol while on statin treatment may reduce the risk of cardiovascular disease (CVD) in people with type 2 diabetes and...
University of Buffalo and Research Team Study Identify Potential Connection Between Chinese Air Pollution and Growing Cardiovascular Disease
The University of Buffalo along with collaborators have provided pathophysiologic evidence that air pollution impacts cardiovascular disease in China. In fact, the findings suggest that China may need to revise its standard for one type of pollutant. Published in JAMA...
University of Waterloo Study Suggests a Sugar Tax Would Reduce Consumption
The University of Waterloo, Canada reviewed the buying behavior of more than 3,500 Canadians when it came to drinks and snacks. The net takeaway: 20% tax increase on high-sugar-based products would lead participants to buy food and drinks with 20% less sugar and 20%...
Wake Forest Baptist Health Study Evidences NASH Diet Significantly Lowers Heart Failure Risk
A Wake Forest School of Medicine led observational study of more than 4,500 individuals revealed those under 75 who adhere to the DASH (Dietary Approaches to Stop Hypertension) diet had significantly lower risk of developing heart failure than those whose...
Study Shows Consuming Walnuts Lowers Risk of Cardiovascular Disease
While it’s not unusual for doctors to recommend certain foods be consumed to avoid health problems down the road, some foods revealed unexpected benefits. A study published recently in the Journal of the American Heart Association showed the positive effects of...
Merck and Partners Real-world Evidence Research Shows Statins Fail to Lower LDL-C Threshold
Patrick Campbell of MD Magazine reports Merck, Regenstrief Institute, Indiana University School of Medicine, and the University of North Carolina Chappell Hill, found 33.7% of statin patients examined failed to reach therapeutic levels of LDL-C which should help...